Please use this identifier to cite or link to this item: https://swslhd.intersearch.com.au/swslhdjspui/handle/1/12960
Full metadata record
DC FieldValueLanguage
dc.contributor.authorCopping, R.-
dc.contributor.authorBalamon, P.-
dc.contributor.authorLau, M.-
dc.contributor.authorCatt, J.-
dc.contributor.authorSchlaphoff, G.-
dc.date.accessioned2024-09-02T05:56:58Z-
dc.date.available2024-09-02T05:56:58Z-
dc.date.issued2024-
dc.identifier.issn17549477 (ISSN)-
dc.identifier.urihttps://swslhd.intersearch.com.au/swslhdjspui/handle/1/12960-
dc.description.abstractIntroduction: Procedural sedation and pain management in interventional radiology (IR) are of critical importance to successful outcomes but remain under-researched. Methoxyflurane has been previously used in some minor procedures with several advantages including rapid onset and offset and a good safety profile. The purpose of this study was to evaluate methoxyflurane for procedures in IR. Methods: A randomised, double-blind, placebo-controlled trial was performed between October 2021 and November 2022. Patients presenting for portacath insertion, portacath removal or solid organ biopsy were randomised to either methoxyflurane or placebo. Three hundred and fourteen patients were enrolled in total. Patients were supplied with one Penthrox inhaler containing either 3 mL methoxyflurane or placebo. The primary endpoints of the study were change in pain and anxiety scores compared with baseline, measured on a standardised visual analogue scale (VAS) pre-procedure, at 5-min intervals during the procedure and post-procedure. Baselines scores were controlled for in the statistical analysis. Safety analysis was also performed. Results: One hundred and sixty-nine patients received methoxyflurane and 145 received placebo. Baseline characteristics were similar between the two groups. The methoxyflurane group had lower pain and anxiety scores throughout the procedure (P < 0.001) with 2.5 times less pain (VAS 1.08/10) and 1.6 times less anxiety (VAS 0.97/10) on average. Lower post-procedure pain (mean 0.72 vs 1.44; P < 0.001) and anxiety (mean 0.55 vs 1.13; P = 0.008) were also observed with methoxyflurane. There were no drug or major procedure-related adverse events. Conclusion: The results of this study suggest that methoxyflurane provides safe and effective analgesia and anxiolysis for some procedures in IR. � 2024 The Author(s). Journal of Medical Imaging and Radiation Oncology published by John Wiley & Sons Australia, Ltd on behalf of Royal Australian and New Zealand College of Radiologists.-
dc.publisherJohn Wiley and Sons Inc-
dc.subjectinterventional radiology methoxyflurane Penthrox procedural sedation-
dc.titleMethOxyfluraNe in InTerventiOnal Radiology (MONITOR): A randomised controlled trial-
dc.typeJournal Article-
dc.contributor.swslhdauthorCopping, Ross-
dc.contributor.swslhdauthorBalamon, Paul-
dc.contributor.swslhdauthorLau, Marcus-
dc.contributor.swslhdauthorCatt, Jules-
dc.contributor.swslhdauthorSchlaphoff, Glen-
dc.description.affiliatesInterventional Radiology Department, Liverpool Hospital, Sydney, NSW, Australia Discipline of Medicine, South West Sydney Clinical Campuses, UNSW Medicine and Health, Sydney, NSW, Australia-
dc.identifier.doi10.1111/1754-9485.13726-
dc.identifier.departmentLiverpool Hospital, Department of Interventional Radiology-
dc.type.studyortrialArticle-
dc.identifier.journaltitleJournal of Medical Imaging and Radiation Oncology-
Appears in Collections:Liverpool Hospital

Files in This Item:
There are no files associated with this item.


Items in Prosentient are protected by copyright, with all rights reserved, unless otherwise indicated.

Google Media

Google ScholarTM

Who's citing